New Guidelines for Psoriatic Arthritis Developed

Guidelines cover diagnosis, assessment and treatment of most significant clinical manifestations

WEDNESDAY, Oct. 29 (HealthDay News) -- The first guidelines for the diagnosis, assessment and treatment of psoriatic arthritis have been developed, according to an article published online Oct. 24 in Annals of the Rheumatic Diseases.

Christopher T. Ritchlin, M.D., of the University of Rochester Medical Center in New York and colleagues developed guidelines for the most significant clinical manifestations of psoriatic arthritis (skin and nails, peripheral arthritis, axial disease, dactylitis and enthesitis) based on a review of the literature and consensus opinion. Treatment recommendations were drafted by rheumatologists, dermatologists and patients with the condition.

The team developed diagnosis, assessment and treatment recommendations for each of the clinical manifestations as well as a grid that factored disease severity into each of the different disease manifestations to help clinicians make treatment decisions. They recommend that patients see a specialist such as a rheumatologist or dermatologist if they suspect psoriasis or psoriatic arthritis. Depending on the manifestation, patients should receive treatment such as phototherapy, nonsteroidal anti-inflammatory drugs such as glucocorticoids, disease-modifying anti-rheumatic drugs such as cyclosporine or drugs that inhibit tumor necrosis factor such as etanercept, infliximab and adalimumab.

"It is anticipated that periodic updates will take place using this framework as new data become available," Ritchlin and colleagues write.

Abstract
Full Text (subscription or payment may be required)

Physician's Briefing